{"product_id":"rectal-cancer-paperback-3","title":"Rectal cancer - Paperback","description":"\u003cdiv\u003e\u003cp style=\"text-align: right;\"\u003e\u003ca href=\"https:\/\/reportcopyrightinfringement.com\/\" target=\"_blank\" rel=\"nofollow\"\u003e\u003cb\u003eReport copyright infringement\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/div\u003e\u003cp\u003eby \u003cb\u003eRichter Igor\u003c\/b\u003e (Author)\u003c\/p\u003e\u003cp\u003eMalignant tumors of the colon and rectum are the most common cancers in developed countries. The incidence of rectal adenocarcinoma represents approximately 30% of this number. A neoadjuvant chemoradiotherapy followed by total mesorectal excision is the current standard of the treatment in patients with locally advanced rectal adenocarcinoma.The aim of this retrospective study was to determine the prognostic impact of EGFR expression changes during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.\u003c\/p\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eNumber of Pages:\u003c\/strong\u003e 56\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eDimensions:\u003c\/strong\u003e 0.13 x 9 x 6 IN\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e December 01, 2015\u003c\/div\u003e\n            ","brand":"BooksCloud","offers":[{"title":"Default Title","offer_id":47339262148857,"sku":"9783659807053","price":44.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0789\/2782\/3097\/files\/QlFkYkhMRElTVHlISFpydkhhODhPUT09_5c88465c-14df-4a62-9266-52bf9bfffb75.webp?v=1769689150","url":"https:\/\/bookscloud.io\/products\/rectal-cancer-paperback-3","provider":"BooksCloud Book Dropshipping","version":"1.0","type":"link"}